Optimax Holdings Berhad

KLSE:OPTIMAX Stock Report

Mkt Cap: RM421.2m

We’ve recently updated our valuation analysis.

Optimax Holdings Berhad Valuation

Is OPTIMAX undervalued compared to its fair value, analyst forecasts and its price relative to the market?

[object Object] Score

2/6

Valuation Score 2/6

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Below Fair Value

  • Significantly Below Fair Value

  • Analyst Forecast

Key Valuation Metric

Which metric is best to use when looking at relative valuation for OPTIMAX?

Other financial metrics that can be useful for relative valuation.

OPTIMAX key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue3.9x
Enterprise Value/EBITDA13.4x
PEG Ratio1.9x

Price to Earnings Ratio vs Peers

How does OPTIMAX's PE Ratio compare to its peers?

The above table shows the PE ratio for OPTIMAX vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyPEEstimated GrowthMarket Cap
Peer Average30.6x
MHCARE Metro Healthcare Berhad
54.5xn/aRM419.4m
TMCLIFE TMC Life Sciences Berhad
23.8xn/aRM1.0b
HONGSENG Hong Seng Consolidated Berhad
11.6xn/aRM1.1b
CENGILD Cengild Medical Berhad
32.4xn/aRM368.5m
OPTIMAX Optimax Holdings Berhad
26.1x14.0%RM402.3m

Price-To-Earnings vs Peers: OPTIMAX is good value based on its Price-To-Earnings Ratio (26.1x) compared to the peer average (30.6x).


Price to Earnings Ratio vs Industry

How does OPTIMAX's PE Ratio compare vs other companies in the Asian Healthcare Industry?

0 CompaniesPrice / EarningsEstimated GrowthMarket Cap
Industry Avg.n/a12.0%
n/an/an/a

Price-To-Earnings vs Industry: OPTIMAX is expensive based on its Price-To-Earnings Ratio (26.1x) compared to the Asian Healthcare industry average (19.4x)


Price to Earnings Ratio vs Fair Ratio

What is OPTIMAX's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

OPTIMAX PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio26.1x
Fair PE Ratio12.2x

Price-To-Earnings vs Fair Ratio: OPTIMAX is expensive based on its Price-To-Earnings Ratio (26.1x) compared to the estimated Fair Price-To-Earnings Ratio (12.1x).


Share Price vs Fair Value

What is the Fair Price of OPTIMAX when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: OPTIMAX (MYR0.78) is trading above our estimate of fair value (MYR0.75)

Significantly Below Fair Value: OPTIMAX is trading above our estimate of fair value.


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst OPTIMAX forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
CurrentRM0.78
RM0.97
+24.4%
11.8%RM1.12RM0.84n/a4
Nov ’23RM0.76
RM0.87
+15.6%
12.5%RM1.04RM0.74n/a4
Oct ’23RM0.75
RM0.87
+16.3%
12.5%RM1.04RM0.74n/a4
Sep ’23RM0.65
RM0.87
+35.3%
12.5%RM1.04RM0.74n/a4
Aug ’23RM0.61
RM0.83
+36.5%
9.7%RM0.94RM0.74n/a4
Jul ’23RM0.56
RM0.86
+55.6%
8.2%RM0.94RM0.77n/a3
Jun ’23RM0.62
RM0.86
+39.2%
8.2%RM0.94RM0.77n/a3
May ’23RM0.61
RM0.79
+29.1%
1.6%RM0.80RM0.78n/a2
Apr ’23RM0.58
RM0.80
+37.9%
0%RM0.80RM0.80n/a1
Mar ’23RM0.62
RM0.80
+29.0%
0%RM0.80RM0.80n/a1
Feb ’23RM0.58
RM0.80
+36.8%
0%RM0.80RM0.80n/a1
Jan ’23RM0.65
RM0.80
+24.0%
0%RM0.80RM0.80n/a1
Dec ’22RM0.68
RM0.72
+6.6%
0%RM0.72RM0.72RM0.781
Nov ’22RM0.68
RM0.72
+7.4%
0%RM0.72RM0.72RM0.761
Oct ’22RM0.69
RM0.72
+4.3%
0%RM0.72RM0.72RM0.751
Sep ’22RM0.71
RM0.72
+2.1%
0%RM0.72RM0.72RM0.651
Aug ’22RM0.63
RM0.70
+12.0%
0%RM0.70RM0.70RM0.611
Jul ’22RM0.71
RM0.70
-2.1%
0%RM0.70RM0.70RM0.561
Jun ’22RM0.73
RM0.70
-4.8%
0%RM0.70RM0.70RM0.621
May ’22RM0.78
RM0.58
-25.6%
20.7%RM0.70RM0.46RM0.612
Apr ’22RM0.82
RM0.60
-26.4%
17.1%RM0.70RM0.46RM0.583
Mar ’22RM0.69
RM0.47
-32.0%
30.3%RM0.65RM0.26RM0.624
Feb ’22RM0.51
RM0.39
-23.8%
44.2%RM0.65RM0.20RM0.586
Jan ’22RM0.47
RM0.39
-17.2%
44.2%RM0.65RM0.20RM0.656
Dec ’21RM0.38
RM0.39
+2.7%
44.2%RM0.65RM0.20RM0.686

Analyst Forecast: Target price is more than 20% higher than the current share price and analysts are within a statistically confident range of agreement.


Discover undervalued companies